significant change in OS or CSS for seminoma (98% and 99% respectively) or NSGCT (96% and 96%) over the study period.
INTRODUCTION AND OBJECTIVES:
The undescended testicle (UDT) presents a problem in post-pubertal (PP) men as it carries an increased risk of developing a testicular germ cell tumor (GCT). Management of the PP patient with an UDT must weigh the relative risk of peri-operative mortality (POM) to remove the UDT against the lifetime risk of death from developing a GCT. The most recent analysis of this management dilemma is 15 years old and utilizes now outdated data. In their paper, investigators found that men who are healthy (ASA 1 or 2) should be advised to undergo orchiectomy, while those older than 50 should be advised to remain under close observation. However, newer studies on the prevalence of UDT, GCT mortality rates and POM risk may change this recommendation. We undertook an update to this previous report as these more contemporary data may establish new criteria in the management of the PP UDT.
METHODS: The most recent data on GCT mortality in the U.S. were obtained from the National Center for Health Statistics. The lifetime risk of death from GCT in the male population was calculated for each 5-year interval. Standard life tables were used to calculate the cumulative risk over a man's lifetime based on the age at presentation. The prevalence of UDT in PP males and the percentage of men with GCT who have a history of UDT were identified through literature search. The relative risk of GCT in men with UDT was expressed as the ratio of observed to expected prevalence of UDT among patients with GCT. The prevalence of UDT in GCT men was calculated as a weighted value based on the number of patients in each individual study. As there is no orchiectomy specific POM data, we utilized data from patients undergoing similar ("low risk") surgical procedures stratified by ASA class. Orchiectomy was considered a low risk procedure based on the Cleveland Clinic cardiac risk stratification for non-cardiac surgery. Mortality rates were plotted to determine the age when ASA class specific POM exceeds the risk of mortality from GCT.
RESULTS: Lifetime risk of dying from GCT decreases with increasing age. POM exceeded risks of death from GCT for men after age 46 for ASA class 1 and age 25 for ASA class 2. Men with an ASA class higher than 2 have a higher risk of POM compared to GCT for all ages.
CONCLUSIONS: Previous evaluations in the management of men with PP UDT required updating. We found a lower age at which observation is advised compared to the previous report. Thus, we advocate for prophylactic orchiectomy only in men who are under 46 years if ASA class 1 and under 25 years if ASA class 2. Men with an ASA class higher than 2 should always undergo observation.
Source of Funding: None

PD09-12 THE IMPACT OF SURGEON AND HOSPITAL EXPERIENCE ON THE PERIOPERATIVE OUTCOMES OF PATIENTS RECEIVING ROBOTIC PARTIAL NEPHRECTOMY
Yash Khandwala*, San Diego, CA; In Gab Jeong, Palo Alto, CA; Ye Wang, Boston, MA; Deok Hyun Han, Seoul, Korea, Republic of; Jae Heon Kim, Seol, Korea, Republic of; Shufeng Li, Palo Alto, CA; Steven L. Chang, Boston, MA; Benjamin I. Chung, Stanford, CA INTRODUCTION AND OBJECTIVES: Robot use for assistance with partial nephrectomies (PN) has increased drastically over the past decade with adoption rates by robot-naive surgeons continuing to rise steadily. Despite this, little is known about the impact of surgeon experience and hospital volume on peri-operative outcomes and the cost of management for patients undergoing robotic PN. Thus, we sought to compare peri-operative success and in-hospital cost between surgeons and hospitals with low, medium and high robotic PN volumes.
METHODS: Utilizing an all-payer hospital clinical and economic database, we identified a nationally representative sample of 50,282 patients undergoing robotic PN within the United States between 2003 and 2015 after survey weighting. Annual surgeon and hospital robotic PN volumes were calculated and surgeons and hospitals were subsequently divided into tertiles corresponding to low, medium and high volumes.
RESULTS: High volume surgeons and hospitals had a significantly higher rate of older patients compared to their peers and were more likely to practice at a hospital that was academic, larger than 500 beds and in an urban setting (all p<0.001). Patients treated by high volume surgeons also had fewer overall complications compared to low volume surgeons (24.4% vs. 31.3%, p ¼0.002) as well as a 35% lower odds of having a major complication after adjusting for relevant patient and hospital characteristics (OR: .65, 95% CI: 0.47 to 0.90, p ¼ 0.009). Hospitals performing a high volume of robotic PN also had fewer overall complications compared to low volume hospitals (24% vs. 27%, p¼0.01) and 43% lower multivariate odds of having a major complication (OR: .57, 95% CI: 0.41 to 0.79, p¼0.001). The patient's length of stay was significantly shorter for both high volume surgeons and hospitals, respectively, compared to low and medium volume surgeons (p<0.001). Total cost of stay after adjusting for inflation was not significantly different regardless of surgeon and hospital experience in robotic PN surgery. The mean decrease in cost for high volume surgeons and hospitals compared to their low volume peers was $28.6 (p¼0.933) and $186.5 (p¼0.56), respectively.
CONCLUSIONS: Increased experience in robotic PN by both surgeons and hospitals is associated with lower complication rates and shorter length of stays, but in-hospital cost is not significantly affected by provider experience.
